Most Read Articles
Roshini Claire Anthony, 17 Jul 2019

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
05 Oct 2019
The combination of sofosbuvir and velpatasvir is safe and effective for the treatment of hepatitis C virus (HCV) in patients with end-stage renal disease (ESRD) undergoing haemodialysis, a study has shown.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.

Nanotechnology structured water shows potential for ED treatment

Audrey Abella
11 May 2018

Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.

“Nanotechnology structured water … is a new type of water that is prepared using different types of energy fields and modulators to produce this nanotechnology structured water that has new and different characteristics from ordinary water,” said the researchers.

A total of 262 men with ED were randomized to receive a daily dose of nanotechnology structured water 20 mL/kg body weight (group A, n=87), tadalafil 5 mg (group B, n=90), or ordinary bottled water 20 mL/kg (group C, n=85) and completed a 3-month evaluation. [EAU 2018, abstract 591]

The degree of ED and treatment success were determined by using the International Index of Erectile Function-Erectile Function (IIEF-EF) domain (questions 1–5, and question 15), Sexual Encounter Profile questions 1 and 2 (SEP1 and SEP2), and Global Assessment questions 1 and 2 (GAQ1 and GAQ2) related to erectile function.

At 3 months, group A participants exhibited significant improvements from baseline in IIEF-EF (from 14.39 to 22.64; p<0.001), SEP1 (from 62 percent to 83 percent; p<0.001), SEP2 (from 35 percent to 77 percent; p<0.001), GAQ1 (85 percent; p<0.001) and GAQ2 (79 percent; p<0.001).

Group B showed similar improvements at 3 months in terms of IIEF-EF (from 13.89 to 27.38; p<0.001), SEP1 (from 60 percent to 89 percent; p<0.001), SEP2 (from 37 percent to 85 percent; p<0.001), GAQ1 (91 percent; p<0.001), and GAQ2 (84 percent; p<0.001).

These findings reflect similar efficacy between nanotechnology structured water and tadalafil, noted the researchers. “Nanotechnology structured water … is a novel way to treat ED patients without the need for expensive medications with no side effects … [and] offers a reasonable and safe way to treat ED,” they said.

The results also support previous evidence reflecting the role of nanotechnology-based vehicles in translational therapy development for diseases such as ED, as it has a unique design for drug delivery and is believed to enhance growth factor effects by providing a platform that offers improved release, penetration, and bioavailability, as well as a localized and sustained method of delivery. [J Sex Med 2017;14:36-43; J Urol 1994;151:54-61; J Sex Med 2004;1:284-1291]

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 17 Jul 2019

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
05 Oct 2019
The combination of sofosbuvir and velpatasvir is safe and effective for the treatment of hepatitis C virus (HCV) in patients with end-stage renal disease (ESRD) undergoing haemodialysis, a study has shown.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.